J Gen Virol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Gen Virol 67 (1986), 1653-1661; DOI 10.1099/0022-1317-67-8-1653
© 1986 Society for General Microbiology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kurane, I.
Right arrow Articles by Ennis, F. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kurane, I.
Right arrow Articles by Ennis, F. A.
Agricola
Right arrow Articles by Kurane, I.
Right arrow Articles by Ennis, F. A.

Induction of Interferon Alpha and Gamma from Human Lymphocytes by Dengue Virus-infected Cells

Ichiro Kurane, Anthony Meager1 and Francis A. Ennis

Division of Infectious Diseases, Department of Medicine, University of Massachusetts Medical Center, Worcester, Massachusetts 01605, U.S.A.
and1 Division of Viral Products, National Institute for Biological Standards and Control, Holly Hill, Hampstead, London NW3 6RB, U.K.

Human peripheral blood lymphocytes (PBL) of non-immune donors produced interferon (IFN) when cultured with dengue virus-infected cells. IFN was detected as early as 2 h after exposure of PBL to dengue virus-infected cells, and the titres reached a maximum by 16 h of incubation. Dengue virus-infected cells treated with glutaraldehyde, which produced no infectious dengue virus, also induced IFN. These results indicate that PBL produce IFN in response to dengue virus-infected cells and that the production of IFN by PBL is due to stimulation of PBL by dengue virus-infected cells. Characterization of IFN-producing PBL with monoclonal antibodies demonstrated that the predominant producing cells were contained in M1+ and T3- subsets, and that the Leu11+ subset contains some IFN-producing cells. The IFNs that were produced by the PBL exposed to dengue virus-infected cells were analysed by radioimmunoassay employing monoclonal antibodies specifically to detect IFN-{alpha} or IFN-{gamma}. IFN-{gamma} as well as IFN-{alpha} was produced by PBL exposed to dengue virus-infected cells. Both IFN-{alpha} and IFN-{gamma} were predominantly produced by PBL contained in M1+ and T3- subsets. The observation that PBL of non-immune donors produced IFN-{gamma} as well as IFN-{alpha} in response to dengue virus-infected cells is of interest in view of the immunoregulatory roles of IFNs and the hypothesis that the complications of dengue virus infection (haemorrhagic fever and shock) may be due to immunopathology.

Keywords: dengue virus, interferon, natural killer cells

Received 19 November 1985; accepted 17 April 1986.


This article has been cited by other articles:


Home page
Postgrad. Med. J.Home page
G N Malavige, S Fernando, D J Fernando, and S L Seneviratne
Dengue viral infections
Postgrad. Med. J., October 1, 2004; 80(948): 588 - 601.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. Shresta, J. L. Kyle, H. M. Snider, M. Basavapatna, P. R. Beatty, and E. Harris
Interferon-Dependent Immunity Is Essential for Resistance to Primary Dengue Virus Infection in Mice, Whereas T- and B-Cell-Dependent Immunity Are Less Critical
J. Virol., March 15, 2004; 78(6): 2701 - 2710.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. M. Gronowski, D. M. Hilbert, K. C. F. Sheehan, G. Garotta, and R. D. Schreiber
Baculovirus Stimulates Antiviral Effects in Mammalian Cells
J. Virol., December 1, 1999; 73(12): 9944 - 9951.
[Abstract] [Full Text]


Home page
J. Virol.Home page
A. J. Johnson and J. T. Roehrig
New Mouse Model for Dengue Virus Vaccine Testing
J. Virol., January 1, 1999; 73(1): 783 - 786.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 1986 by the Society for General Microbiology.